The future belongs to those who believe in multiplex CAR T engineering

Key Points

• Multiplex CAR T engineering improves the targeting of multiple tumor antigens, enhancing therapeutic effectiveness.
• This approach may allow for more precise immunotherapy options, potentially altering treatment pathways for various cancers.
• Analysis focuses on innovative genetic engineering techniques to develop next-generation CAR T therapies for better outcomes.
• Future work supports advancing multiplex strategies, with broader applications in cancer immunotherapy anticipated.